12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lexapro cipralex escitalopram regulatory update

Mochida submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for escitalopram to treat depression. Mochida has Japanese development and commercialization rights to escitalopram from Lundbeck.

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >